Home/Filings/4/0001209191-15-019666
4//SEC Filing

HISTOGENICS CORP 4

Accession 0001209191-15-019666

$OCGNCIK 0001372299operating

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 5:00 PM ET

Size

8.1 KB

Accession

0001209191-15-019666

Insider Transaction Report

Form 4
Period: 2015-02-26
Gridley Adam
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2015-02-26+104,000104,000 total
    Exercise: $9.96Exp: 2025-02-26Common Stock (104,000 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2015-02-26+60,00060,000 total
    Exercise: $9.96Exp: 2025-02-26Common Stock (60,000 underlying)
Footnotes (2)
  • [F1]This option vests over four (4) years of service following February 26, 2016, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and in thirty-six (36) equal monthly installments thereafter.
  • [F2]This option shall vest in full if the Issuer's Common Stock price reaches $19.92 per shares or above for any consecutive sixty (60) day period within four (4) years of the date of grant (the "Vesting Date"). In addition, if this option is exercised within one (1) year of the Vesting Date, the Reporting Person must hold shares (net of taxes) until the one (1) year anniversary of the Vesting Date.

Issuer

HISTOGENICS CORP

CIK 0001372299

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001372299

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:00 PM ET
Size
8.1 KB